Hello. Sign in to personalize your visit. New user? Register now.  
Diabetes Technology & Therapeutics
The Intelligent Dosing System: Application for Insulin Therapy and Diabetes Management

To cite this article:
Curtiss B. Cook, John P. McMichael, Ron Lieberman, Linda J. Mann, Esther C. King, Katina M. New, Pamela S. Vaughn, Virginia G. Dunbar, Jane M. Caudle. Diabetes Technology & Therapeutics. February 2005, 7(1): 58-71. doi:10.1089/dia.2005.7.58.

Full Text: • PDF for printing (194.1 KB) • PDF w/ links (233.7 KB)


Curtiss B. Cook, M.D.
Division of Endocrinology, Mayo Clinic, Scottsdale, Arizona.
John P. McMichael, B.S.
Dimensional Dosing Systems, Wexford, Pennsylvania.
Ron Lieberman, M.D.
Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland.
Linda J. Mann, B.S.N.
Grady Health System, Atlanta, Georgia.
Esther C. King, B.S.N.
Grady Health System, Atlanta, Georgia.
Katina M. New, M.S.
Grady Health System, Atlanta, Georgia.
Pamela S. Vaughn, B.S.N.
Grady Health System, Atlanta, Georgia.
Virginia G. Dunbar, B.S.
Grady Health System, Atlanta, Georgia.
Jane M. Caudle, M.Ln.
Grady Health System, Atlanta, Georgia.

Diabetes mellitus is an increasing public health problem. Insulin is an essential tool in the management of hyperglycemia, but methods of dose adjustment are purely empirical. The Intelligent Dosing System (IDS®, Dimensional Dosing Systems, Inc., Wexford, PA) is a software suite that incorporates patient-specific, dose–response data in a mathematical model and then calculates the new dose of the medication needed to achieve the next desired therapeutic goal. We discuss the application of the IDS in insulin management. The IDS concept and the initial modeling used to construct an insulin doser are reviewed first. Additional data are then provided on the use of the IDS for titrating insulin therapy in a clinical setting. Finally, recent modifications in the IDS software and future applications of this technology for insulin dosing and diabetes management are discussed.

Free first page

This paper was cited by:

Description and Preliminary Evaluation of a Multiagent Intelligent Dosing System (MAIDS™) to Manage Combination Insulin–Oral Agent Therapy in Type 2 Diabetes
Curtiss B. Cook, John P. Mcmichael, Virginia G. Dunbar, Ron Lieberman
Diabetes Technology & Therapeutics. Dec 2005, Vol. 7, No. 6: 937-947
Abstract | Full Text PDF | Reprints & Permissions
Response to Bequette and Desemone Regarding the Intelligent Dosing System
Curtiss B. Cook, John P. McMichael
Diabetes Technology & Therapeutics. Aug 2005, Vol. 7, No. 4: 658-661
First Page | Full Text PDF | Reprints & Permissions
Editorial: Symposium on Algorithms for Continuous Glucose Monitoring and Control
B. Wayne Bequette
Diabetes Technology & Therapeutics. Feb 2005, Vol. 7, No. 1: 1-2
First Page | Full Text PDF | Reprints & Permissions
All articles
Previous Next